Matches in SemOpenAlex for { <https://semopenalex.org/work/W2360100400> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- W2360100400 abstract "Objective To study the application value ATP bioluminescence tumor chemosensitivity assay (ATP-TCA) directed individual neoadjuvant chemotherapy in patients with non-small cell lung cancer (NSCLC).Methods The study included 79 patients with stage Ⅱ～Ⅲ NSCLC.We tested the specimens from 40 patients for chemosensitivity using ATP-TCA.32 were given the most suitable regimen according to testing,and 39 were allocated to receive a standard regimen of platinum-containing doublet chemotherapy as controls.Results Available evaluation of specimen is 92.5%.Four platinum-containing combined chemotherapy regimens:GEN and DDP (GP) regimen,DOC and DDP(DP) regimen,NVB and DDP(NP) regimen,TAX and DDP(TP) regimen were carried out,and the in vitro effective rates of GP,DP,NP and TP were 81.1%,78.4%,62.2% and 59.5%,respectively.The response rate of neoadjuvant chemotherapy and the resection rate were 78.1% and 93.8% in test group,64.1% and 82.9% in control group,respectively(P0.05). But the response rate evaluated by pathological evaluation was 78.1% for the test group,much better than the control group's 54.3% (P0.05).Conclusions ATP-TCA might be useful in planning individualized neoadjuvant chemotherapy regimen for NSCLC patient.Effect of neoadjuvant chemotherapy should be evaluated by the grading of pathological changes." @default.
- W2360100400 created "2016-06-24" @default.
- W2360100400 creator A5049202258 @default.
- W2360100400 date "2008-01-01" @default.
- W2360100400 modified "2023-09-23" @default.
- W2360100400 title "Application of adenosine triphosphate tumor chemosensitive assay system to individual neoadjuvant chemotherapy for non-small-cell lung cancer" @default.
- W2360100400 hasPublicationYear "2008" @default.
- W2360100400 type Work @default.
- W2360100400 sameAs 2360100400 @default.
- W2360100400 citedByCount "0" @default.
- W2360100400 crossrefType "journal-article" @default.
- W2360100400 hasAuthorship W2360100400A5049202258 @default.
- W2360100400 hasConcept C121608353 @default.
- W2360100400 hasConcept C126322002 @default.
- W2360100400 hasConcept C143998085 @default.
- W2360100400 hasConcept C2776256026 @default.
- W2360100400 hasConcept C2776694085 @default.
- W2360100400 hasConcept C2778076430 @default.
- W2360100400 hasConcept C2778292576 @default.
- W2360100400 hasConcept C2778336483 @default.
- W2360100400 hasConcept C2781413609 @default.
- W2360100400 hasConcept C530470458 @default.
- W2360100400 hasConcept C71924100 @default.
- W2360100400 hasConceptScore W2360100400C121608353 @default.
- W2360100400 hasConceptScore W2360100400C126322002 @default.
- W2360100400 hasConceptScore W2360100400C143998085 @default.
- W2360100400 hasConceptScore W2360100400C2776256026 @default.
- W2360100400 hasConceptScore W2360100400C2776694085 @default.
- W2360100400 hasConceptScore W2360100400C2778076430 @default.
- W2360100400 hasConceptScore W2360100400C2778292576 @default.
- W2360100400 hasConceptScore W2360100400C2778336483 @default.
- W2360100400 hasConceptScore W2360100400C2781413609 @default.
- W2360100400 hasConceptScore W2360100400C530470458 @default.
- W2360100400 hasConceptScore W2360100400C71924100 @default.
- W2360100400 hasLocation W23601004001 @default.
- W2360100400 hasOpenAccess W2360100400 @default.
- W2360100400 hasPrimaryLocation W23601004001 @default.
- W2360100400 isParatext "false" @default.
- W2360100400 isRetracted "false" @default.
- W2360100400 magId "2360100400" @default.
- W2360100400 workType "article" @default.